dopamine D2/serotonin 2A antagonists (Pfizer)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedopamine D2/serotonin 2A antagonists (Pfizer)
Drug Alias Namedopamine D2/5-HT2A antagonists (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D2 receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A